The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 13, 2022

Filed:

Oct. 14, 2021
Applicant:

Invisishield Technologies Ltd., Emeryville, CA (US);

Inventors:

Cheng Liu, Orinda, CA (US);

Hongbing Zhang, Moraga, CA (US);

Zhiyuan Yang, Albany, CA (US);

Jingyi Xiang, Walnut Creek, CA (US);

Ziyou Cui, Moraga, CA (US);

Jianying Liu, Albany, CA (US);

Assignee:

InvisiShield Technologies Ltd., Emeryville, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/10 (2006.01); C07K 14/47 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 19/00 (2006.01); C12N 15/63 (2006.01); A61K 39/395 (2006.01); A61K 38/08 (2019.01); A61K 38/10 (2006.01); A61K 38/17 (2006.01); A61P 31/14 (2006.01); A61K 9/00 (2006.01); A61K 47/20 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/10 (2013.01); A61K 9/0043 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 38/17 (2013.01); A61K 39/3955 (2013.01); A61K 47/20 (2013.01); A61P 31/14 (2018.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/47 (2013.01); C07K 19/00 (2013.01); C12N 15/63 (2013.01); A61K 2039/505 (2013.01); A61K 2039/543 (2013.01); C07K 2317/21 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C07K 2319/01 (2013.01); C07K 2319/035 (2013.01); C07K 2319/30 (2013.01); C07K 2319/33 (2013.01);
Abstract

The present application relates to compositions for preventing or treating viral and other microbial infections. In some embodiments, the present application provides chimeric proteins comprising a target-binding moiety that specifically binds to a pathogen that infects through a mucosa, and a positively charged mucoadhesive peptide fragment. Also provided are antibodies and constructs thereof that specifically binds to an S1 subunit of a spike protein of SARS-CoV-2. Compositions comprising the chimeric proteins, antibodies, or constructs described herein are useful for preventing or treating a microbial infection in an individual, such as a coronavirus infection.


Find Patent Forward Citations

Loading…